BRLF1 109-117 (HLA-A*02:01)
€50.00 *
Prices plus VAT plus shipping costs
Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt
- Order number: EP11139_1
Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells... more
Product information "BRLF1 109-117 (HLA-A*02:01)"
Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
YVLDHLIVV is a linear peptidic epitope (epitope ID76333) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
YVLDHLIVV is a linear peptidic epitope (epitope ID76333) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity and tested in T cell assays as well as MHC ligand assay.
| Sequence: | YVLDHLIVV | |
| Gene: | ATF7IP | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Purity: | 95% | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Activating transcription factor 7-interacting protein 1 | |
| Species: | Human | |
| Allele: | HLA-A*02:01 | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Safety data sheets
Viewed